S(-)-PINDOLOL
|
|
S(-)-PINDOLOL Eigenschaften
- Siedepunkt:
- 457.1±35.0 °C(Predicted)
- Dichte
- 1.152±0.06 g/cm3(Predicted)
- storage temp.
- Desiccate at +4°C
- L?slichkeit
- 0.1 M NaOH: 0.2 mg/mL
- Aggregatzustand
- solid
- pka
- 13.94±0.20(Predicted)
- Farbe
- white
- Optische Aktivit?t
- [α]23/D 4.38°, c = 1% in methanol(lit.)
Sicherheit
WGK Germany | 3 |
---|
S(-)-PINDOLOL Chemische Eigenschaften,Einsatz,Produktion Methoden
Biologische Aktivit?t
5-HT 1A/1B ? receptor antagonist, with roughly equal affinity for each subtype. A partial agonist at mouse and human β 3 -adrenoceptors. More active enantiomer of pindolol (1-(1H-Indol-4-yloxy)-3-[(1-methylethyl)amino]-2-propanol ).S(-)-PINDOLOL Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
S(-)-PINDOLOL Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 36)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 |
marketing@targetmol.com | United States | 32161 | 58 |
Wuhan Topule Biopharmaceutical Co., Ltd | +8618327326525 |
masar@topule.com | China | 8467 | 58 |
Shenyang Zhongshen Zekang Biomedical Technology Research Co., Ltd | +86-18341751992 +86-15382112998 |
757984502@qq.com | China | 892 | 58 |
Aladdin Scientific | +1-+1(833)-552-7181 |
sales@aladdinsci.com | United States | 52924 | 58 |
Wuhan Jingkang en Biomedical Technology Co., Ltd | +8613720134139 |
orders@jknbiochem.com | China | 5221 | 58 |
Amadis Chemical Company Limited | 571-89925085 |
sales@amadischem.com | China | 131957 | 58 |
3B Pharmachem (Wuhan) International Co.,Ltd. | 821-50328103-801 18930552037 |
3bsc@sina.com | China | 15839 | 69 |
EMMX Biotechnology LLC | 888-539-0666 |
info@emmx.com | United States | 8447 | 60 |
Pharmacodia (Beijing) Co.,Ltd | +86-400-851-9921 |
sales@pharmacodia.com | China | 2317 | 55 |
Shanghai Han-Xiang Chemical Co., Ltd. | 15971444841 |
amber@biochempartner.com | China | 3061 | 58 |
26328-11-0()Verwandte Suche:
1-(1H-indol-4-yloxy)-3-((1-methyl-ethyl)amino)-2-propanol
(±)-1-(1H-Indol-4-yloxy)-3-(isopropylamino)propan-2-olhydrochlorid
- L-PINDOLOL
- (S)-1-(1H-INDOL-4-YLOXY)-3-[(1-METHYLETHYL)AMINO]-2-PROPANOL
- S(-)-PINDOLOL
- (-)-PINDOLOL B-ADRENERGIC BLOCKING
- 2-Propanol, 1-(1H-indol-4-yloxy)-3-[(1-methylethyl)amino]-, (2S)- (9CI)
- 2-Propanol, 1-(1H-indol-4-yloxy)-3-[(1-methylethyl)amino]-, (S)-
- (2S)-1-(1H-Indole-4-yloxy)-3-(isopropylamino)propane-2-ol
- (S)-1-(1H-Indole-4-yloxy)-3-[(1-methylethyl)amino]-2-propanol
- [S,(-)]-1-(1H-Indole-4-yloxy)-3-(isopropylamino)-2-propanol
- 2-Propanol, 1-(1H-indol-4-yloxy)-3-[(1-Methylethyl)aMino]-, (2S)-
- MT-102
- S(-)-Pindolol (S)-1-((1H-indol-4-yl)oxy)-3-(dimethylamino)propan-2-ol
- AGI-001
- 26328-11-0
- 26382-11-0
- Building Blocks
- Heterocyclic Building Blocks
- Indoles
- Adrenergics
- Antagonists
- Neurotransmitters